BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23311251)

  • 1. [Fluorescence in situ hybridization in hematology].
    Milosević I; Popović S; Urosević I
    Vojnosanit Pregl; 2012 Nov; 69(11):986-93. PubMed ID: 23311251
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic application of FISH to hematological malignancies.
    Najfeld V
    Cancer Invest; 2003; 21(5):807-14. PubMed ID: 14628438
    [No Abstract]   [Full Text] [Related]  

  • 3. [FISH, interphase cytogenetics, gene rearrangements].
    Taniwaki M
    Rinsho Ketsueki; 1998 Feb; 39(2):75-7. PubMed ID: 9545801
    [No Abstract]   [Full Text] [Related]  

  • 4. [Essentials of conventional and molecular cytogenetics: application to diagnosis of hematological malignancies].
    Lafage-Pochitaloff M
    Pathol Biol (Paris); 2003 Aug; 51(6):307-11. PubMed ID: 12927887
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cytogenetics and molecular genetics of hematological malignancy].
    Izutsu K
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():304-8. PubMed ID: 17474424
    [No Abstract]   [Full Text] [Related]  

  • 6. [Minimal residual disease in hematology].
    Rák K
    Orv Hetil; 2001 May; 142(21):1091-5. PubMed ID: 11449837
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chromosomal analysis, fluorescence in situ hybridization method, and spectral karyotyping in hematologic malignancies].
    Nara N
    Rinsho Byori; 2003 Jun; Suppl 126():124-30. PubMed ID: 12905952
    [No Abstract]   [Full Text] [Related]  

  • 8. [Novel diagnostic procedures for hematologic malignancies on the basis of genomic alterations].
    Taniwaki M
    Rinsho Ketsueki; 2001 May; 42(5):352-5. PubMed ID: 11452449
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies.
    Kolialexi A; Tsangaris GT; Kitsiou S; Kanavakis E; Mavrou A
    Anticancer Res; 2005; 25(4):2979-83. PubMed ID: 16080555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetics.
    Kearney L
    Best Pract Res Clin Haematol; 2001 Sep; 14(3):645-69. PubMed ID: 11640874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the new fish technologies on the cytogenetics of haematological malignancies.
    Kearney L
    Br J Haematol; 1999 Mar; 104(4):648-58. PubMed ID: 10192422
    [No Abstract]   [Full Text] [Related]  

  • 12. [The hematological malignancies related to primary hypereosinophilia and their diagnostics].
    Skonieczka K; Matiakowska K; Haus O
    Postepy Hig Med Dosw (Online); 2014 Dec; 68():1530-7. PubMed ID: 25834096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicolor FISH.
    Jalal SM; Law ME
    Methods Mol Biol; 2002; 204():105-20. PubMed ID: 12397793
    [No Abstract]   [Full Text] [Related]  

  • 14. Multimodality Technologies in the Assessment of Hematolymphoid Neoplasms.
    Li S; Jaye DL; Bradley KT; Zhang L; Saxe D; Deeb G; Hill CE; Mann KP
    Arch Pathol Lab Med; 2017 Mar; 141(3):341-354. PubMed ID: 28055240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of abnormal numbers of chromosome 8 with interphase fluorescence in situ hybridization in hematologic malignancies].
    Wang HP; Li GX; Qiao ZH; Wang HW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):395-7. PubMed ID: 15300644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7q22 deletion in myeloid malignancies: be attentive to the design of the FISH probe.
    Struski S; Luquet I
    Ann Biol Clin (Paris); 2019 Apr; 77(2):229-230. PubMed ID: 30907375
    [No Abstract]   [Full Text] [Related]  

  • 17. [Priority of using conventional cytogenetics, in situ hybridization and PCR in the study of hematologic neoplasms].
    Solé F; Espinet B; Woessner S
    Sangre (Barc); 1998 Feb; 43(1):3-5. PubMed ID: 9577175
    [No Abstract]   [Full Text] [Related]  

  • 18. Clonality determined by fluorescence in situ hybridization of single-cell aberrations in hematopoietic neoplasias.
    Gebhart T; Liehr T
    Cancer Genet Cytogenet; 1999 Sep; 113(2):193-4. PubMed ID: 10484992
    [No Abstract]   [Full Text] [Related]  

  • 19. Oligo-based High-resolution aCGH Analysis Enhances Routine Cytogenetic Diagnostics in Haematological Malignancies.
    Kjeldsen E
    Cancer Genomics Proteomics; 2015; 12(6):301-37. PubMed ID: 26543079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetics in the management of hematologic malignancies: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
    Nguyen-Khac F; Daudignon A; Eclache V; Lafage-Pochitaloff M; Lefebvre C; Luquet I; Penther D
    Ann Biol Clin (Paris); 2016 Oct; 74(5):509-510. PubMed ID: 27465598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.